Dan Feng

ConfometRx, Inc.

0000-0001-9516-4144

Projects

COVID-19: Rapid identification of drugs to treat COVID-19 pneumonia

Lead Institution

ConfometRx, Inc.

Principal Investigator

Bingfa Sun

Our proposal establishes that the angiotensin type 2 receptor (AT2R) as a potential therapeutic target for COVID-19 pneumonia. There is a growing body of evidence that activation of AT2R reduces lung…